STAND. COM. REP. NO. 1928

Honolulu, Hawaii

, 2019

RE: S.B. No. 535

S.D. 1

H.D. 1

Honorable Scott K. Saiki

Speaker, House of Representatives

Thirtieth State Legislature

Regular Session of 2019

State of Hawaii

Sir:

Your Committee on Judiciary, to which was referred S.B. No. 535, S.D. 1, H.D. 1, entitled:

"A BILL FOR AN ACT RELATING TO PHARMACISTS PRESCRIBING AND DISPENSING OF OPIOID ANTAGONIST,"

begs leave to report as follows:

The purpose of this measure is to clarify that pharmacists, acting in good faith and exercising reasonable care, may prescribe and dispense an opioid antagonist to both an individual at risk for an opioid overdose or a family member or caregiver of an at-risk individual who is requesting the opioid antagonist.

Your Committee notes that pharmacists are statutorily required to complete a training program related to prescribing opioid antagonists before prescribing and dispensing opioid antagonists.

The Department of Health, Board of Pharmacy, Daniel K. Inouye College of Pharmacy of the University of Hawai‘i at Hilo, Walgreen Co., Kaiser Permanente Hawai‘i, Drug Policy Forum of Hawai‘i, Hawaii Medical Service Association, Hawaii Substance Abuse Coalition, and O‘ahu County Committee on Legislative Priorities of the Democratic Party of Hawai‘i testified in support of this measure.

As affirmed by the record of votes of the members of your Committee on Judiciary that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 535, S.D. 1, H.D. 1, and recommends that it pass Third Reading.

Respectfully submitted on behalf of the members of the Committee on Judiciary,

____________________________

CHRIS LEE, Chair